Management of single malignant lung nodules in elderly patients (70 Years or Older) who are not candidates for lobectomy

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 35, Issue 5, 2012, Pages 480-485

  Parashar, Bhupesh ^a   Patel, Priti ^a   Singh, Prabhsimranjot ^a   Monni, Stefano ^a   Trichter, Samuel ^a   Sabbas, Albert ^a   Wernicke, A Gabriella ^a   Nori, Dattatreyudu ^a   Chao, K S Clifford ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

brachytherapy; cesium 131; elderly; I 125; lung; stereotactic

Indexed keywords

CESIUM 131; IODINE 125; RADIOACTIVE SEED;

AGED; ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CANCER SURVIVAL; CLINICAL ARTICLE; ELDERLY CARE; FEMALE; HUMAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; MALE; MEDICAL RECORD REVIEW; RANDOMIZED CONTROLLED TRIAL (TOPIC); STEREOTACTIC BODY RADIATION THERAPY; TREATMENT FAILURE;

ADENOCARCINOMA; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAOPERATIVE PERIOD; IODINE RADIOISOTOPES; LUNG NEOPLASMS; MALE; PROSTHESES AND IMPLANTS; RETROSPECTIVE STUDIES; SMALL CELL LUNG CARCINOMA; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84866740938     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31821a496d     Document Type: Article

References (32)

1. Blomgren H, Lax I, Naslund I, et al. Stereotactic high dose fraction radiation therapy of extracranial tumours using an accelerator. Acta Oncol. 1995;34:861-870.
2. Powell JW, Dexter E, Scalzetti EM, et al. Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trials. Lancet Oncol. 2009;10:885-894.
3. Santos R, Colonias A, Parda D, et al. Comparison between sublobar resection and 125 I brachytherapy following sublobar resection in high-risk patients with stage 1 non-small cell lung cancer. Surgery. 2003;134:691-697.
4. Lee W, Daly BD, DiPetrillo TA, et al. Limited resection for non-small cell lung cancer: observed local recurrence with implantation of I-125 brachytherapy seeds. Ann Thorac Surg. 2003;75: 237-242.
5. Shennib H, Bogart JA, Herndon J, et al. Thoracoscopic wedge resection and radiotherapy for T1N0 non-small lung cancer: preliminary analysis of a Cancer and Leukemia Group B and Eastern Oncology Group phase II trial. Int Radiat Oncol Bio Phys. 2000;48(3 suppl):232. Abstract 240.
6. Cackler S, Abbas G. RFA is an effective alternative to lobectomy for lung cancer. JAAPA. 2009;22:25-28.
7. Ries LAG, Eisner MP, Kosary CL. SEER Cancer Statistics Review 1975-2000. Bethesda, MD: National Cancer Institute; 2003.
8. Lewis JH, Kilgore ML, Goldman DP, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol. 2003;21:1383-1389.
9. Keenan RJ, Landreneau RJ, Maley RH Jr, et al. Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg. 2004;78:228-233.
10. Harada H, Okada M, Sakamoto T, et al. Functional advantage after radical segmentectomy versus lobectomy for lung cancer. Ann Thorac Surg. 2005;80:2041-2045.
11. Yoshimoto K, Nomori H, Mori T, et al. Quantification of the impact of segmentectomy on pulmonary function by perfusion single-photon-emission computed tomography and multidetector computed tomography. J Thorac Cardiovasc Surg. 2009;137: 1200-1205.
12. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg. 1995;60:615-621.
13. Lafitte JJ, Ribet ME, Prevost BM, et al. Postresection irradiation for T2 N0 M0 non-small cell carcinoma: a prospective, randomized study. Ann Thorac Surg. 1996;62:830-834.
14. Feld R, Rubinstein LV, Weisenberger TH. Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies. J Clin Oncol. 1984;2:1352-1358.
15. Kato H, Ichinose Y, Ohta M, et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med. 2004;350:1713-1721.
16. Lardinois D, Suter H, Hakki H, et al. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Ann Thorac Surg. 2005;80:268-274; discussion 274-275.
17. Harpole DH Jr, Herndon JE Jr, Young WG Jr, et al. Stage I nonsmall cell lung cancer: a multivariate analysis of treatment methods and patterns of recurrence. Cancer. 1995;76:787-796.
18. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg. 1995;109:120-129.
19. Grills IS, Mangona VS, Welsh R, et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol. 2010;28:928-935.
20. Onishi H, Shirato H, Nagata Y, et al. Hypo-fractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol. 2007;2:94-100.
21. Xiao L, Li Z, Wu L, et al. Sequential treatment of superior vena cava syndrome caused by of non-small cell carcinoma lung cancer (NSCLC) with vascular stenting and iodine-125 implantation. Technol Cancer Res Treat. 2009;8:281-287.
22. Zhang FJ, Li CX, Wu PH, et al. CT guided radioactive 125I seed implantation in treating localized advanced pulmonary carcinoma. Zhonghua Yi Xue Za Zhi. 2007;87:3272-3275. Chinese.
23. Trombetta MG, Colonias A, Makishi D, et al. Tolerance of the aorta using intraoperative iodine-125 interstitial brachytherapy in cancer of the lung. Brachytherapy. 2008;7:50-54.
24. Peters N, Wieners G, Pech M, et al. CT-guided interstitial brach ytherapy of primary and secondary lung malignancies: results of a prospective phase II trial. Strahlenther Onkol. 2008;184:296-301.
25. Martínez-Monge R, Pagola M, Vivas I, et al. CT-guided permanent brachytherapy for patients with medically inoperable early-stage non-small cell lung cancer (NSCLC). Lung Cancer. 2008;61:209-213.
26. McKenna RJ Jr, Mahtabifard A, Yap J, et al. Wedge resection and brachytherapy for lung cancer in patients with poor pulmonary function. Ann Thorac Surg. 2008;85:S733-S736.
27. Weiss T, Langer C. NSCLC in the elderly: the legacy of therapeutic neglect. Curr Treat Options Oncol. 2009;10: 180-194.
28. Hutchins LF, Unger JM, Crowley JJ, et al. Underrepresentation of patients 65 years of age or older in cancer treatment trials. N Engl J Med. 1999;341:2061-2067.
29. Jatoi A, Hillman S, Stella P, et al. Should elderly non-smallcell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. J Clin Oncol. 2005;23:9113-9119.
30. Berry MF, Hanna J, Tong BC, et al. Risk factors for morbidity after lobectomy for lung cancer in elderly patients. Ann Thorac Surg. 2009;88:1093-1099.
31. Goodgame B, Viswanathan A, Zoole J, et al. Risk of recurrence of resected stage I non-small cell lung cancer in elderly patients as compared with younger patients. J Thorac Oncol. 2009;4: 1370-1374.
32. Parashar B, Patel P, Monni S, et al. Limited resection followed by intraoperative seed implantation is comparable to stereotactic body radiotherapy for solitary lung cancer. Cancer. 2010;116: 5047-5053.